Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosing Flexibility Study of Tlando in Hypogonadism
NCT03242408Phase 3Completed
- Sponsor
- Lipocine Inc
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of TSX-011 in Hypogonadism, sponsored by Lipocine Inc. Started Jan 2017; status: completed.
02
Drugs
TSX-011
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03242408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242408.